Literature DB >> 15983754

[Painless jaundice after holidays in Tanzania].

R R Plentz1, H Lenzen, M P Manns, J S Bleck.   

Abstract

The side effects caused by malaria prophylaxis with mefloquine (Lariam) are well known. We describe the case of a 42-year-old female Caucasian patient suffering from painless jaundice and showing elevated liver, cholestasis and inflammation laboratory findings 7 days after returning from Tanzania. Acute cholecystitis was diagnosed by ultrasound. Treatment with parenteral nutrition and antibiotic therapy did not show any beneficial effect. Excluding the possibility of infectious diseases, the elevated laboratory and ultrasound findings were normalized after the discontinuation of the malaria prophylaxis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15983754     DOI: 10.1007/s00108-005-1458-x

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  8 in total

1.  Safety and efficacy of liposomal amphotericin B in allogeneic bone marrow transplant recipients.

Authors:  E E Andström; O Ringdén; M Remberger; B M Svahn; J Tollemar
Journal:  Mycoses       Date:  1996 May-Jun       Impact factor: 4.377

2.  Comparison of adverse events associated with use of mefloquine and combination of chloroquine and proguanil as antimalarial prophylaxis: postal and telephone survey of travellers.

Authors:  P J Barrett; P D Emmins; P D Clarke; D J Bradley
Journal:  BMJ       Date:  1996-08-31

3.  Atovaquone-proguanil versus mefloquine for malaria prophylaxis in nonimmune travelers: results from a randomized, double-blind study.

Authors:  D Overbosch; H Schilthuis; U Bienzle; R H Behrens; K C Kain; P D Clarke; S Toovey; J Knobloch; H D Nothdurft; D Shaw; N S Roskell; J D Chulay
Journal:  Clin Infect Dis       Date:  2001-09-05       Impact factor: 9.079

4.  Serious adverse events of mefloquine in relation to blood level and gender.

Authors:  E Schwartz; I Potasman; M Rotenberg; S Almog; S Sadetzki
Journal:  Am J Trop Med Hyg       Date:  2001-09       Impact factor: 2.345

Review 5.  Drug-induced gallbladder disease. Incidence, aetiology and management.

Authors:  P P Michielsen; H Fierens; Y M Van Maercke
Journal:  Drug Saf       Date:  1992 Jan-Feb       Impact factor: 5.606

6.  Malaria Chemoprophylaxis in German Tourists: A Prospective Study on Compliance and Adverse Reactions.

Authors: 
Journal:  J Travel Med       Date:  1996-09-01       Impact factor: 8.490

7.  Development of mefloquine as an antimalarial drug. UNDP/World Bank/WHO update.

Authors: 
Journal:  Bull World Health Organ       Date:  1983       Impact factor: 9.408

8.  Abnormal liver function in patients undergoing autologous bone marrow transplantation for hematological malignancies.

Authors:  C Wasserheit; L Acaba; S Gulati
Journal:  Cancer Invest       Date:  1995       Impact factor: 2.176

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.